Cargando…

Intra-abdominal packing does not increase infection risk or mandate longer presumptive antibiotic therapy

BACKGROUND: Damage control laparotomy allows for resuscitation and reversal of coagulopathy with improved mortality. Intra-abdominal packing is often used to limit hemorrhage. Temporary abdominal closure is associated with increased rates of subsequent intra-abdominal infection. The effect of increa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Parker, Uhlich, Rindi, Pierce, Virginia, Cox, Thomas, Kerby, Jeffrey, Bosarge, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kare Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277336/
https://www.ncbi.nlm.nih.gov/pubmed/37145040
http://dx.doi.org/10.14744/tjtes.2022.64438
_version_ 1785060255980322816
author Hu, Parker
Uhlich, Rindi
Pierce, Virginia
Cox, Thomas
Kerby, Jeffrey
Bosarge, Patrick
author_facet Hu, Parker
Uhlich, Rindi
Pierce, Virginia
Cox, Thomas
Kerby, Jeffrey
Bosarge, Patrick
author_sort Hu, Parker
collection PubMed
description BACKGROUND: Damage control laparotomy allows for resuscitation and reversal of coagulopathy with improved mortality. Intra-abdominal packing is often used to limit hemorrhage. Temporary abdominal closure is associated with increased rates of subsequent intra-abdominal infection. The effect of increased duration of antibiotics is unknown on these infection rates. We sought to determine the role of antibiotics in damage control surgery. METHODS: A retrospective analysis of all trauma patients requiring damage control laparotomy on admission to an ACS verified level one trauma center from 2011 to 2016 was performed. Demographic and clinical data including ability and time to attain primary fascial closure, as well as complication rates, were recorded. The primary outcome measure was intra-abdominal abscess formation following damage control laparotomy. RESULTS: Two-hundred and thirty-nine patients underwent DCS during the study period. A majority were packed (141/239, 59.0%). No differences existed in demographics or injury severity between groups, and infection rates were similar (30.5% vs. 38.8%, P=0.18). Patients with infection were more likely to have suffered gastric injury (23.3% vs. 6.1%, P=0.003) than those without complication. There was no significant association between gram negative and anaerobic (Odds Radio [OR] 0.96, 95% confidence interval [CI] 0.87–1.05) or antifungal therapy (OR 0.98, 95% CI 0.74–1.31) and infection rate, regardless of duration on multivariate regression CONCLUSION: Our study offers the first review of the effect of antibiotic duration on intra-abdominal complications following DCS. Gastric injury was more commonly identified in patients who developed intra-abdominal infection. Duration of antimicrobial therapy does not affect infection rate in patients who are packed following DCS.
format Online
Article
Text
id pubmed-10277336
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Kare Publishing
record_format MEDLINE/PubMed
spelling pubmed-102773362023-06-20 Intra-abdominal packing does not increase infection risk or mandate longer presumptive antibiotic therapy Hu, Parker Uhlich, Rindi Pierce, Virginia Cox, Thomas Kerby, Jeffrey Bosarge, Patrick Ulus Travma Acil Cerrahi Derg Original Article BACKGROUND: Damage control laparotomy allows for resuscitation and reversal of coagulopathy with improved mortality. Intra-abdominal packing is often used to limit hemorrhage. Temporary abdominal closure is associated with increased rates of subsequent intra-abdominal infection. The effect of increased duration of antibiotics is unknown on these infection rates. We sought to determine the role of antibiotics in damage control surgery. METHODS: A retrospective analysis of all trauma patients requiring damage control laparotomy on admission to an ACS verified level one trauma center from 2011 to 2016 was performed. Demographic and clinical data including ability and time to attain primary fascial closure, as well as complication rates, were recorded. The primary outcome measure was intra-abdominal abscess formation following damage control laparotomy. RESULTS: Two-hundred and thirty-nine patients underwent DCS during the study period. A majority were packed (141/239, 59.0%). No differences existed in demographics or injury severity between groups, and infection rates were similar (30.5% vs. 38.8%, P=0.18). Patients with infection were more likely to have suffered gastric injury (23.3% vs. 6.1%, P=0.003) than those without complication. There was no significant association between gram negative and anaerobic (Odds Radio [OR] 0.96, 95% confidence interval [CI] 0.87–1.05) or antifungal therapy (OR 0.98, 95% CI 0.74–1.31) and infection rate, regardless of duration on multivariate regression CONCLUSION: Our study offers the first review of the effect of antibiotic duration on intra-abdominal complications following DCS. Gastric injury was more commonly identified in patients who developed intra-abdominal infection. Duration of antimicrobial therapy does not affect infection rate in patients who are packed following DCS. Kare Publishing 2023-05-02 /pmc/articles/PMC10277336/ /pubmed/37145040 http://dx.doi.org/10.14744/tjtes.2022.64438 Text en Copyright © 2023 Turkish Journal of Trauma and Emergency Surgery https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
spellingShingle Original Article
Hu, Parker
Uhlich, Rindi
Pierce, Virginia
Cox, Thomas
Kerby, Jeffrey
Bosarge, Patrick
Intra-abdominal packing does not increase infection risk or mandate longer presumptive antibiotic therapy
title Intra-abdominal packing does not increase infection risk or mandate longer presumptive antibiotic therapy
title_full Intra-abdominal packing does not increase infection risk or mandate longer presumptive antibiotic therapy
title_fullStr Intra-abdominal packing does not increase infection risk or mandate longer presumptive antibiotic therapy
title_full_unstemmed Intra-abdominal packing does not increase infection risk or mandate longer presumptive antibiotic therapy
title_short Intra-abdominal packing does not increase infection risk or mandate longer presumptive antibiotic therapy
title_sort intra-abdominal packing does not increase infection risk or mandate longer presumptive antibiotic therapy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277336/
https://www.ncbi.nlm.nih.gov/pubmed/37145040
http://dx.doi.org/10.14744/tjtes.2022.64438
work_keys_str_mv AT huparker intraabdominalpackingdoesnotincreaseinfectionriskormandatelongerpresumptiveantibiotictherapy
AT uhlichrindi intraabdominalpackingdoesnotincreaseinfectionriskormandatelongerpresumptiveantibiotictherapy
AT piercevirginia intraabdominalpackingdoesnotincreaseinfectionriskormandatelongerpresumptiveantibiotictherapy
AT coxthomas intraabdominalpackingdoesnotincreaseinfectionriskormandatelongerpresumptiveantibiotictherapy
AT kerbyjeffrey intraabdominalpackingdoesnotincreaseinfectionriskormandatelongerpresumptiveantibiotictherapy
AT bosargepatrick intraabdominalpackingdoesnotincreaseinfectionriskormandatelongerpresumptiveantibiotictherapy